share_log

リボミック:umedaptanib pegol(抗FGF2アプタマー)に関する製剤特許の欧州特許登録のお知らせ

Ribomic: Notice of European Patent Registration for Formulation Patents Related to umedaptanib pegol (anti-FGF2 aptamer)

JPX ·  Sep 13 11:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more